- Home
- Equipment
- netherlands
- patient management
Refine by
Patient Management Equipment Supplied In Netherlands
7 equipment items found
Manufactured by:Philips Healthcare based inAmsterdam, NETHERLANDS
IQon delivers confident decision making, innovative analytics, and uncompromised workflow that dramatically impact patient management and economic ...
Manufactured by:Philips Healthcare based inAmsterdam, NETHERLANDS
With proprietary Digital Photon Counting technology for outstanding advances all along the imaging chain, Vereos exemplifies an established total solution to reveal more, earlier, to help you improve patient care and manage ...
Manufactured by:ANT Neuro based inHengelo, NETHERLANDS
visor2™ is the neuronavigation solution for the most advanced neuroscience research and accurate clinical therapy with non-invasive transcranial magnetic stimulation ...
Manufactured by:Self-screen B.V. based inAmsterdam, NETHERLANDS
The QIAsure Methylation Test is intended to be used as a triage test for women with a positive HPV DNA test or for women with ASC-US cytology to identify those women who need to be referred for colposcopy. The QIAsure Methylation Test is a multiplex real-time methylation specific PCR-based (qMSP) assay that detects hyper methylation of 2 disease related marker genes, FAM19A4 and mir124-2, to ...
Manufactured by:AMST-SMIT based inUniversity Park, ILLINOIS (USA)
The mobile PET/CT unit comprises advanced technologies such as high-performance detectors and reconstruction algorithms, allowing for better patient throughput and image quality. Various standard features include integrated patient data management and ergonomic patient handling features. Customizable options for the unit include ...
Manufactured by:MDxHealth based inIrvine, CALIFORNIA (USA)
ConfirmMDx Addresses Prostate Biopsy Sampling Error and the False-Negative Biopsy Dilemma. “Rule-in” high-risk men who have had a previous negative biopsy result, may be harboring undetected cancer (a false-negative biopsy result), and therefore may benefit from a repeat biopsy and appropriate treatment. “Rule-out” otherwise cancer-free men from undergoing unnecessary ...
Manufactured by:MDxHealth based inIrvine, CALIFORNIA (USA)
SelectMDx Helps Physicians Determine if a Patient is at Higher or Lower Risk for Prostate Cancer and Which Men Can Safely Avoid Biopsy. A non-invasive urine test (“liquid biopsy”), SelectMDx measures the expression of two mRNA cancer-related biomarkers (HOXC6 and DLX1).1 The test provides binary results that, when combined with the patient’s clinical risk factors, help the ...